Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), sold 254,265 shares at $9.35 ($2.4M) on 2017-11-27, disclosed to the SEC on 2017-11-29.
Open-market sale of $2.4M AVDL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2017-05-22 | $305K | — | Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |
| ANF | BUY | 2016-09-06 | $177K | — | Filing → |